Comparison of long-term prognostic evaluation between pre-intervention thrombolysis and primary coronary intervention: A prospective randomized trial - Five-year results of the IMPORTANT study

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1625-1634

  Itoh, Tomonori ^a   Fukami, Ken'ichi ^a   Suzuki, Tomomi ^a   Kimura, Takumi ^a   Kanaya, Yoshinori ^a   Orii, Makoto ^a   Goto, Iwao ^a   Matsui, Hiroki ^a   Sugawara, Shoma ^a   Nakajima, Satoshi ^a   Fusazaki, Tetsuya ^a   Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Percutaneous coronary intervention; Reperfusion; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONTEPLASE; NICORANDIL; NITRATE; THIENOPYRIDINE DERIVATIVE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL TIME; TREATMENT RESPONSE; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; DISEASE-FREE SURVIVAL; HUMANS; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77955065757     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0873     Document Type: Article

References (27)

1. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
3. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol 1996; 27: 1646-1655.
4. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283: 2941-2947.
5. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-e292.
6. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003; 361: 13-20.
7. Aoki H, Suzuki T, Shibata M, Takino T, Sato N, Mukaida H, et al. A prospective randomized trial of intracoronary t-PA versus coronary angioplasty in acute myocardial infarction: Japanese Intervention Trial in Myocardial Infarction (JIMI). Circulation 1997; 96(Suppl): I536.
8. Boersma E, for The Primary Coronary Angioplasty vs Thromboly-sis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fbrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27: 779-788.
9. Mehta RH, Harjai KJ, Cox DA, Stone GW, Brodie BR, Boura J, et al. Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2005; 96: 901-906.
10. Herrmann HC, Moliterno DJ, Ohman EM, Stebbins AL, Bode C, Betriu A, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 2000; 36: 1489-1496.
11. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT investigators: Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999; 34: 1954-1962.
12. Assessment of the Safety and Effcacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomized trial. Lancet 2006; 367: 569-578.
13. Di Pasquale P, Cannizzaro S, Parrinello G, Giambanco F, Vitale G, Fasullo S, et al. Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings. J Thromb Thrombolysis 2006; 21: 147-157.
14. Yasuda S, Shimokawa H. Acute myocardial infarction: The enduring challenge for cardiac protection and survival. Circ J 2009; 73: 2000-2008.
15. Kaneko H, Yaoita H, Iwai-Takano M, Watanabe N, Sakamoto K, Seino Y, et al. Prediction of remote left ventricular volumes and functions after acute myocardial infarction with successful coronary intervention. Circ J 2008; 72: 226-231.
16. TIMI Study Group: Thrombolysis in myocardial infarction (TIMI) trials: Phase I fndings. N Engl J Med 1985; 312: 932-936.
17. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Benefcial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003; 42: 634-641.
18. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J, et al. Routine invasive strategy within 24 h of thrombolysis versus ischemia guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomized controlled trial. Lancet 2004; 364: 1045-1053.
19. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myo-cardial infarction: Quantitative review of randomized trials. Lancet 2006; 367: 579-588.
20. Gulba DC, Barthels M, Reil GH, Lichtlen PR. Thrombin/antithrom-bin-III complex level as early predictor of reocclusion after successful thrombolysis. Lancet 1988; 2: 97.
21. Widimský P, Budesínský T, Vorác D, Groch L, Zelízko M, Aschermann M, et al. Long distance transport for primary angio-plasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial: PRAGUE-2. Eur Heart J 2003; 24: 94-104.
22. Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, et al. Comparison of primary angioplasty and pre-hospital fibri-nolysis in acute myocardial infarction (CAPTIM) trial: A 5-year follow-up. Eur Heart J 2009; 30: 1598-1606.
23. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-2217.
24. Fernández-Avilés F, Alonso JJ, Peña G, Blanco J, Alonso-Briales J, López-Mesa J, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: The GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007; 28: 949-960.
25. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008; 117: 296-329.
26. Dudek D, Rakowski T, Dziewierz A, Kleczynski P. PCI after lytic therapy: When and how? Eur Heart J Suppl 2008; 10: J15-J20.
27. McKay RG, Dada MR, Mather JF, Mennet RR, Murphy DJ, Maloney KW, et al. Comparison of outcomes and safety of 'facilitated' versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2009; 103: 316-321.